Advertisement
U.S. Markets open in 1 hr 4 mins

Zealand Pharma A/S (0NZU.IL)

IOB - IOB Delayed Price. Currency in DKK
841.50+28.75 (+3.54%)
As of 12:29PM GMT. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
76,870
342,788
103,986
108,546
192,001
Cost of Revenue
21,478
19,174
0
10,970
0
Gross Profit
55,392
323,614
103,986
97,576
192,001
Operating Expense
1,186,780
900,831
920,585
879,720
818,236
Operating Income
-1,131,388
-577,217
-816,599
-782,144
-626,235
Net Non Operating Interest Income Expense
225,788
16,343
-48,681
-7,520
-6,620
Other Income Expense
-
-
-
30,777
-4,068
Pretax Income
-1,057,157
-708,865
-972,041
-758,887
-673,527
Tax Provision
-4,613
-5,126
-6,431
-3,949
-4,814
Net Income Common Stockholders
-1,052,544
-703,739
-1,202,135
-1,018,149
-846,729
Diluted NI Available to Com Stockholders
-1,052,544
-703,739
-1,202,135
-1,018,149
-846,729
Basic EPS
-14.58
-12.44
-26.02
-23.75
-22.07
Diluted EPS
-14.58
-12.44
-26.02
-23.75
-22.07
Basic Average Shares
54,753
56,589
46,200
42,869
38,370
Diluted Average Shares
54,753
56,589
46,200
42,869
38,370
Total Operating Income as Reported
-1,126,409
-572,238
-837,153
-784,317
-626,235
Total Expenses
1,208,258
920,005
920,585
890,690
818,236
Net Income from Continuing & Discontinued Operation
-1,052,544
-703,739
-1,202,135
-1,018,149
-846,729
Normalized Income
-936,403
-566,456
-834,123
-749,221
-667,554
Interest Income
123,911
45,324
6,542
44
895
Interest Expense
27,968
24,888
56,455
4,091
2,895
Net Interest Income
225,788
16,343
-48,681
-7,520
-6,620
EBIT
-1,029,189
-683,977
-915,586
-754,796
-670,632
EBITDA
-1,001,113
-658,891
-797,625
-711,850
-627,940
Reconciled Cost of Revenue
21,478
19,174
0
10,970
0
Reconciled Depreciation
28,076
25,086
117,961
42,946
42,692
Net Income from Continuing Operation Net Minority Interest
-1,052,544
-703,739
-965,610
-754,938
-668,713
Total Unusual Items Excluding Goodwill
-116,650
-138,283
-132,363
-5,747
-1,167
Total Unusual Items
-116,650
-138,283
-132,363
-5,747
-1,167
Normalized EBITDA
-884,463
-520,608
-665,262
-706,103
-626,773
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-509.0128
-999.9628
-875.7104
-29.9055
-8.3411